Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 157

1.

Artesunate exerts specific cytotoxicity in retinoblastoma cells via CD71.

Zhao F, Wang H, Kunda P, Chen X, Liu QL, Liu T.

Oncol Rep. 2013 Sep;30(3):1473-82. doi: 10.3892/or.2013.2574. Epub 2013 Jun 28.

PMID:
23818062
2.

Reversal of stathmin-mediated microtubule destabilization sensitizes retinoblastoma cells to a low dose of antimicrotubule agents: a novel synergistic therapeutic intervention.

Mitra M, Kandalam M, Sundaram CS, Verma RS, Maheswari UK, Swaminathan S, Krishnakumar S.

Invest Ophthalmol Vis Sci. 2011 Jul 23;52(8):5441-8. doi: 10.1167/iovs.10-6973.

PMID:
21546534
3.

Cytokine-induced killer cells co-cultured with complete tumor antigen-loaded dendritic cells, have enhanced selective cytotoxicity on carboplatin-resistant retinoblastoma cells.

Wang YF, Kunda PE, Lin JW, Wang H, Chen XM, Liu QL, Liu T.

Oncol Rep. 2013 May;29(5):1841-50. doi: 10.3892/or.2013.2315. Epub 2013 Feb 28.

PMID:
23450314
4.

Basic fibroblast growth factor impact on retinoblastoma progression and survival.

Cebulla CM, Jockovich ME, Piña Y, Boutrid H, Alegret A, Kulak A, Hackam AS, Bhattacharya SK, Feuer WJ, Murray TG.

Invest Ophthalmol Vis Sci. 2008 Dec;49(12):5215-21. doi: 10.1167/iovs.07-1668. Epub 2008 Jul 9.

5.

Synergistic Effect of Curcumin in Combination with Anticancer Agents in Human Retinoblastoma Cancer Cell Lines.

Sreenivasan S, Krishnakumar S.

Curr Eye Res. 2015;40(11):1153-65. doi: 10.3109/02713683.2014.987870. Epub 2014 Dec 11.

PMID:
25495096
6.

Vitamin D analogs, a new treatment for retinoblastoma: The first Ellsworth Lecture.

Albert DM, Nickells RW, Gamm DM, Zimbric ML, Schlamp CL, Lindstrom MJ, Audo I.

Ophthalmic Genet. 2002 Sep;23(3):137-56.

PMID:
12324873
7.

Effect of curcumin on miRNA expression in human Y79 retinoblastoma cells.

Sreenivasan S, Thirumalai K, Danda R, Krishnakumar S.

Curr Eye Res. 2012 May;37(5):421-8. doi: 10.3109/02713683.2011.647224.

PMID:
22510010
8.

Microarray analysis and biochemical correlations of oxidative stress responsive genes in retinoblastoma.

Vandhana S, Lakshmi TS, Indra D, Deepa PR, Krishnakumar S.

Curr Eye Res. 2012 Sep;37(9):830-41. doi: 10.3109/02713683.2012.678544. Epub 2012 Jun 5.

PMID:
22668346
9.

Antiproliferative and apoptotic effects of indomethacin on human retinoblastoma cell line Y79 and the involvement of β-catenin, nuclear factor-κB and Akt signaling pathways.

Zheng Q, Zhang Y, Ren Y, Wu Y, Yang S, Zhang Y, Chen H, Li W, Zhu Y.

Ophthalmic Res. 2014;51(2):109-15. doi: 10.1159/000355844. Epub 2013 Dec 19.

PMID:
24355977
10.

1,25-dihydroxyvitamin D3-induced apoptosis of retinoblastoma cells is associated with reciprocal changes of Bcl-2 and bax.

Wagner N, Wagner KD, Schley G, Badiali L, Theres H, Scholz H.

Exp Eye Res. 2003 Jul;77(1):1-9.

PMID:
12823982
11.

Effect of curcumin on lung resistance-related protein (LRP) in retinoblastoma cells.

Thiyagarajan S, Thirumalai K, Nirmala S, Biswas J, Krishnakumar S.

Curr Eye Res. 2009 Oct;34(10):845-51. doi: 10.3109/02713680903125329.

PMID:
19895312
12.

RB116: an RB1+ retinoblastoma cell line expressing primitive markers.

Bejjani A, Choi MR, Cassidy L, Collins DW, O'Brien JM, Murray T, Ksander BR, Seigel GM.

Mol Vis. 2012;18:2805-13. Epub 2012 Nov 29.

13.

The apoptotic effects of cisplatin and carboplatin in retinoblastoma Y79 cells.

Di Felice V, Lauricella M, Giuliano M, Emanuele S, Vento R, Tesoriere G.

Int J Oncol. 1998 Aug;13(2):225-32.

PMID:
9664115
14.

Evaluation of the in vitro and in vivo antitumor activity of histone deacetylase inhibitors for the therapy of retinoblastoma.

Dalgard CL, Van Quill KR, O'Brien JM.

Clin Cancer Res. 2008 May 15;14(10):3113-23. doi: 10.1158/1078-0432.CCR-07-4836.

15.

Differential microRNA-34a expression and tumor suppressor function in retinoblastoma cells.

Dalgard CL, Gonzalez M, deNiro JE, O'Brien JM.

Invest Ophthalmol Vis Sci. 2009 Oct;50(10):4542-51. doi: 10.1167/iovs.09-3520. Epub 2009 May 14.

PMID:
19443717
16.

L1 increases adhesion-mediated proliferation and chemoresistance of retinoblastoma.

Jo DH, Lee K, Kim JH, Jun HO, Kim Y, Cho YL, Yu YS, Min JK, Kim JH.

Oncotarget. 2017 Feb 28;8(9):15441-15452. doi: 10.18632/oncotarget.14487.

17.

Upregulation of sodium iodide symporter (NIS) protein expression by an innate immunity component: Promising potential for targeting radiosensitive retinoblastoma.

Samuel J, Singh N, Kanwar JR, Krishnakumar S, Kanwar RK.

Exp Eye Res. 2015 Oct;139:108-14. doi: 10.1016/j.exer.2015.07.011. Epub 2015 Jul 23.

PMID:
26213306
18.

The Bcl-2/Bcl-XL inhibitor ABT-737 promotes death of retinoblastoma cancer cells.

Allaman-Pillet N, Oberson A, Munier F, Schorderet DF.

Ophthalmic Genet. 2013 Mar-Jun;34(1-2):1-13. doi: 10.3109/13816810.2011.615077. Epub 2011 Sep 28.

PMID:
21955141
19.

Topotecan combination chemotherapy in two new rodent models of retinoblastoma.

Laurie NA, Gray JK, Zhang J, Leggas M, Relling M, Egorin M, Stewart C, Dyer MA.

Clin Cancer Res. 2005 Oct 15;11(20):7569-78. Erratum in: Clin Cancer Res. 2009 May 15;15(10):3643.

20.

The anti-malarial artesunate is also active against cancer.

Efferth T, Dunstan H, Sauerbrey A, Miyachi H, Chitambar CR.

Int J Oncol. 2001 Apr;18(4):767-73.

PMID:
11251172

Supplemental Content

Support Center